The discovery of the immune suppressive protein, TGM1, which mimics TGF-β, from a helminth parasite which itself can suppress intestinal inflammation (Leung et al., 2012), led us to test the ability of recombinant TGM1 to inhibit inflammatory bowel disease in the well-characterized mouse model of DSS. Here, TGFB1 is linked to inflammatory bowel disease.